ANGEL
COSME JIMENEZ
Investigador/a en el periodo 2005-2010
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Pío del Río Hortega (7)
2021
-
European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain
Antibiotics, Vol. 10, Núm. 1, pp. 1-15
-
Follow-up study confirms the presence of gastric cancer dna methylation hallmarks in high-risk precursor lesions
Cancers, Vol. 13, Núm. 11
2018
-
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14
International Journal of Cancer, Vol. 143, Núm. 11, pp. 2777-2786
2016
-
Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study
Journal of Gastroenterology and Hepatology (Australia), Vol. 31, Núm. 5, pp. 953-958
2011
-
Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)
Scandinavian Journal of Gastroenterology, Vol. 46, Núm. 2, pp. 236-246
2010
-
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin
Digestive and Liver Disease, Vol. 42, Núm. 4, pp. 287-290
2008
-
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 patients
American Journal of Gastroenterology, Vol. 103, Núm. 1, pp. 71-76